epidermal growth factor biosimilar (USV)

N/A

Report date: 2025/01/26 19:31:06

Base Information

Drug Nameepidermal growth factor biosimilar (USV)
Drug Alias Nameepidermal growth factorEGF
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsBurnsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUSV Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUSV Pvt Ltd
Inactive CompaniesN/A
Active IndicationsBurnsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A